Li Yang

机构：Chinese Academy of Sciences, Beijing Tian Tan Hospital, Shanghai Institute of Materia Medica, Fujian Institute of Research on the Structure of Matter, Institute of Geology and Geophysics · ORCID：0000-0001-6829-8278

发表论文 51 篇 · 总被引 946 次 · h-index 20

代表论文

• Identification of SARS-CoV-2 entry inhibitors among already approved drugs (2020 · Acta Pharmacologica Sinica · 被引 97)
• Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives (2019 · ACS Infectious Diseases · 被引 68)
• Overview of therapeutic drug research for COVID-19 in China (2020 · Acta Pharmacologica Sinica · 被引 59)
• Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors (2020 · Journal of Medicinal Chemistry · 被引 27)
• Small Molecule Inhibitors of Hepatitis B Virus Nucleocapsid Assembly: A New Approach to Treat Chronic HBV Infection (2017 · Current Medicinal Chemistry · 被引 22)
• Discovery and optimization of phthalazinone derivatives as a new class of potent dengue virus inhibitors (2018 · European Journal of Medicinal Chemistry · 被引 20)